← All companies
NEKTAR THERAPEUTICS
NKTR - CIK 0000906709
Market cap$1.93 B
Rank#2118
SEC filings1,949
The table below shows NEKTAR THERAPEUTICS's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $15.12M | $44.25M | $35.28M | $88.23M | $25.22M | $198.96M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | $0.00 | $1.21M | $5.98M | $22.49M | $38.89M |
| Inventory | $0.00 | $0.00 | $16.10M | $19.20M | $15.80M | $15.29M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.